PVCTPROVECTUS BIOPHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of PROVECTUS BIOPHARMACEUTICALS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PVCT본 종목 | — | — | — | — | -45.5%#7 | 15.6%#7 | -1575.3%#3 | — | — | — | — | — |
| PRFX | $855531#7 | — | 0.1x#1 | 50.3x#1 | — | 65.6%#3 | -30129.4%#8 | -58.8%#3 | — | — | -84.7%#6 | — |
| PRQR | $196M#4 | — | — | — | — | — | — | — | — | — | -6.3%#3 | — |
| PRTCY | — | — | — | — | 475.3%#2 | 181.4%#1 | -3154.0%#6 | 12.9%#1 | — | — | — | — |
| PTCHF | — | — | — | — | 475.3%#2 | 181.4%#1 | -3154.0%#6 | 12.9%#1 | — | — | — | — |
| QNRX | $485M#3 | — | 123.3x#5 | — | — | -75.6%#9 | — | -401.8%#7 | — | — | -3.9%#2 | — |
| QNTM | $44#8 | — | — | — | — | — | — | — | — | — | -78.4%#5 | — |
| QUCY | $112M#6 | — | 5.5x#3 | 208.2x#4 | -39.9%#5 | 24.9%#4 | -3005.0%#5 | -79.6%#5 | -203.8%#1 | — | — | — |
| QURE | $2.7B#2 | — | 17.9x#4 | 166.3x#3 | -40.6%#6 | 16.9%#6 | -1151.4%#2 | -133.3%#6 | -263.3%#2 | — | — | — |
| RADX | $3.8B#1 | — | — | 1041.4x#5 | 1114.3%#1 | 20.0%#5 | -1050.6%#1 | — | — | — | -77.3%#4 | — |
| RANI | $139M#5 | — | 3.5x#2 | 84.9x#2 | 58.9%#4 | 1.1%#8 | -2346.0%#4 | -75.6%#4 | — | — | 55.7%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice